Several different medicines can be used for sclerotherapy. Bleomycin is just one of those options. Most sclerotherapy medicines act by causing irritation or inflammation of a malformation, followed by scarring. Bleomycin is an antibiotic drug that can also cause gradual cell breakdown or destruction, so that malformations slowly become less bulky. As it causes no immediate irritation of the malformation, it is often less painful and it usually causes very little swelling. It causes less inflammation of the nearby tissues, so the risks of skin or nerve damage are much reduced. It takes longer to work than most other sclerotherapy medicines, and is not effective in every case. Bleomycin may be better at shrinking microcystic lymphatic malformations than the other medicines available. It may be useful for treating malformations in areas where swelling may be dangerous, such as near the eye or airway or for malformations that are in the skin surface or near important nerves.
Bleomycin is a medicine that has been used for many years to treat other conditions. In a very few cases, when it has been used in much higher doses and has been injected straight into the bloodstream, patients have developed some scarring of their lungs several months later, meaning that they cannot take in as big a breath as previously. Sometimes this is permanent. Doctors think this is extremely unlikely to happen in children where bleomycin is being used for sclerotherapy, as the doses are much, much lower and the medicine is not given in the same way. However, we will check your child’s lungs before the procedure, usually using a chest x-ray and some simple breathing tests. This gives a baseline picture of your child’s healthy lungs. If we need to test their lungs again later, we have the baseline picture against which to compare the new picture.
Six to 12 months after your child’s final bleomycin sclerotherapy procedure, they will be offered an appointment with a specialist lung doctor who will also repeat the lung tests to confirm that nothing has changed.
Very rarely, bleomycin can cause some discolouration of the skin or nails or make some hair fall out. This usually, but not always, gets better with time. We think that the skin is more likely to be affected if there are monitoring leads or plasters stuck to the skin at the time of treatment. During your child’s procedure, we will be very careful with how we attach monitoring leads, cannulas and bandages to your child’s skin. Scratching of the skin during the first 48 hours after treatment may cause skin marking. We recommend you buff your child’s fingernails very short before the procedure to minimise the risk of scratching.